News
1d
News-Medical.Net on MSNTirzepatide rewires appetite and slashes calorie intake in new obesity trialA 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with ...
A new review suggests that tirzepatide (Mounjaro, Zepbound) may have neuroprotective mechanisms that could help reduce the ...
GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain ...
In adults with obesity and prediabetes, weight loss achieved with tirzepatide was sustained at more than 3 years, according ...
In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...
Over 100 cases of acute pancreatitis have been reported to UK health regulators this year, many tied to the newest GLP-1 drug ...
Editor Sofia Lind questions the lack of planning, support and infrastructure for GPs among the rollout of tirzepatide in ...
10h
Futurism on MSNOzempic-Style Drugs Linked To Hundreds of Illnesses and DeathsThe UK's health regulator is investigating Ozempic and Mounjaro after linking the drugs to hundreds of severe illnesses and ...
Scholar Rock's Apitegromab excels in Phase 2 trials, aiding muscle preservation with Tirzepatide. Click here to read why I ...
GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan ...
3d
Everyday Health on MSNCould One of These Drugs Be the Next Ozempic?The next generation of diabetes and weight loss drugs could come in pill form, deliver even greater weight loss results, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results